Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
about
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)Mycobacterium ulcerans in the Elderly: More Severe Disease and Suboptimal OutcomesBuruli ulcer in South Western Nigeria: a retrospective cohort study of patients treated in Benin.Development of a dry-reagent-based qPCR to facilitate the diagnosis of Mycobacterium ulcerans infection in endemic countries.Buruli Ulcer Disease and Its Association with Land Cover in Southwestern GhanaA Field Study in Benin to Investigate the Role of Mosquitoes and Other Flying Insects in the Ecology of Mycobacterium ulceransClinical Epidemiology of Buruli Ulcer from Benin (2005-2013): Effect of Time-Delay to Diagnosis on Clinical Forms and Severe PhenotypesTreatment Outcome of Patients with Buruli Ulcer Disease in Togo.Loop-Mediated Isothermal Amplification for Laboratory Confirmation of Buruli Ulcer Disease-Towards a Point-of-Care Test.The "Buruli Score": Development of a Multivariable Prediction Model for Diagnosis of Mycobacterium ulcerans Infection in Individuals with Ulcerative Skin Lesions, Akonolinga, Cameroon.Burden and Historical Trend of Buruli Ulcer Prevalence in Selected Communities along the Offin River of GhanaIntegrated Control and Management of Neglected Tropical Skin DiseasesA genome wide association study identifies a lncRna as risk factor for pathological inflammatory responses in leprosy.Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection.Buruli ulcer in Nigeria: results of a pilot case study in three rural districts.An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulceransAntibiotic Complications During the Treatment of Mycobacterium ulcerans Disease in Australian Patients.Diagnosis delay and duration of hospitalisation of patients with Buruli ulcer in Nigeria.FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.The chemistry and biology of mycolactones.Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection.Increased Severity and Spread of Mycobacterium ulcerans, Southeastern Australia.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.Economic inequality caused by feedbacks between poverty and the dynamics of a rare tropical disease: the case of Buruli ulcer in sub-Saharan Africa.Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer.Report of a series of 82 cases of Buruli ulcer from Nigeria treated in Benin, from 2006 to 2016.Human genetics of mycobacterial diseaseImproving clinical and epidemiological predictors of Buruli ulcer
P2860
Q24186073-23EC227F-9995-4531-93C3-DFD1F528DB55Q28551237-4BA81CAD-A247-4558-AAED-2DD486FE6C80Q34875359-44571B22-B75B-4701-B5AD-96334EA91EA3Q35241003-21F86DF3-34A3-436D-95CB-26FB88FC6B79Q35668815-6E76F36D-30FE-4E83-8E1B-862FFBB4FF6FQ35702681-4B0A1296-83A3-466E-AA66-48FF317848AAQ35768998-044251FB-A353-488B-B240-0E665C3B69ACQ35810457-17B8293B-CFCB-4DB2-8A65-12D15CA5B8E2Q35840888-92A64ACC-DA21-40B5-8739-B61001B69370Q35979570-F60A9FE8-077C-47A3-B5A9-C5E9634231A3Q35989764-9DE1853D-9979-4C28-A763-6CDA5B164217Q36253801-05CBA640-72FE-4CFB-AFD2-80CBBED747E3Q36286140-E6F0DA8A-0CCF-426F-8B34-77620032E103Q36291527-31F157F6-C254-47D5-8538-89EFC3072F0FQ36618316-7AD8DF9E-538B-45C7-B43A-066B2D162695Q36828007-7506F3FC-53A9-4CA1-96B9-7E121C2E2A0CQ37719029-01314356-4E52-4C17-9755-92EA41C441C6Q38741481-993E83EB-4524-4797-A26A-8640309C1503Q39165073-BF6E6FBD-8B39-4388-9D8C-1A7EE683B79EQ39215467-9DE4204C-133D-4773-B0E0-84120148247DQ39432050-F89B4883-4384-499B-85D4-41FD5AAA81E9Q41469222-A2B8F741-5DC7-454C-A92E-DE02E8487DC8Q42205104-B5458ABE-537D-4AB1-B3F7-BC7EA606D859Q43168426-DAFBCCFD-30B0-461E-BE01-6348F7114631Q46241939-F618E9DE-9F30-43FA-92C9-A5C9BE67671CQ51325790-DA98C072-A322-4315-9CEE-0B93BA2EAF9CQ51738497-04CAF89D-F133-4285-917C-F1F105A6E8FFQ53688072-C1CC74AF-06B1-46CC-985F-CF37DFCD2AFCQ55360806-F3A989FA-08D5-4884-B334-489893E50723Q58772716-1801A2A9-4E0A-4C94-9128-5FFFC9393FA5Q58798763-28DF5537-2494-49F5-B0C7-B2521D49078F
P2860
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
@en
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
@nl
type
label
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
@en
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
@nl
prefLabel
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
@en
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
@nl
P2093
P1476
Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
@en
P2093
Aimé Goundote
Alexandre Alcaïs
Ambroise Adeye
Annick Chauty
Christian Johnson
Didier Agossadou
Jane Cottin
Jean-Paul Saint-André
Laurent Marsollier
Marie Kempf
P304
P356
10.1016/S2214-109X(14)70223-2
P577
2014-06-17T00:00:00Z